Taxane‐platinum‐fluoropyrimidine combinations vs taxane‐platinum (without fluoropyrimidine)
Progression‐free survival · people with advanced gastric cancer
Taxane‐platinum‐fluoropyrimidine combinations probably leads to lower progression‐free survival compared with taxane‐platinum (without fluoropyrimidine) (moderate certainty).
1 finding from 1 review
- OR 0.74 [0.59, 0.93]3 studies · 482 participantsModerate